Skip to main content
NanHua Bio-medicine CO.,Ltd． logo

NanHua Bio-medicine CO.,Ltd． — Investor Relations & Filings

Ticker · 000504 ISIN · CNE000000263 Shenzhen Stock Exchange Professional, scientific and technical activities
Open in API
Filings indexed 2,578 across all filing types
Latest filing 2026-05-20 Declaration of Voting R…
Country CN China
Listing Shenzhen Stock Exchange 000504

About NanHua Bio-medicine CO.,Ltd．

https://www.landfar.cn

NanHua Bio-medicine CO.,Ltd. specializes in the research, development, and application of cell-based therapies and regenerative medicine. The company operates comprehensive facilities for stem cell storage, including umbilical cord and cord blood banking services. Its core activities encompass the clinical transformation of cellular technologies, precision medical diagnostics, and the development of biological products. NanHua Bio-medicine integrates upstream cell resource preservation with downstream clinical applications, focusing on providing advanced healthcare solutions through biotechnology. The organization maintains a commitment to scientific innovation in cell biology, utilizing standardized laboratory practices to support the treatment of complex diseases and improve public health outcomes.

Recent filings

Filing Released Lang Actions
南华生物2025年年度股东会决议公告
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is an official announcement of the 2025 annual general meeting resolutions and detailed voting results for each proposal. It lists attendance, vote counts (for, against, abstain) for multiple proposals, and includes legal opinions confirming vote validity. This matches the definition of a Declaration of Voting Results & Voting Rights Announcement (DVA).
2026-05-20 Chinese
南华生物关于申请撤销公司股票退市风险警示的公告
Delisting Announcement Classification · 95% confidence The document is an official announcement from a company regarding its application to revoke a delisting risk warning on its stock. It references the company's audited financial results for 2025 and compliance with stock exchange listing rules, but it does not contain the full annual report or detailed financial statements itself. The document is relatively short (1369 characters) and serves as a formal notice about the status of the delisting risk warning and the application submitted to the Shenzhen Stock Exchange. This fits the definition of a Delisting Announcement (DLST), as it concerns the company's stock delisting risk status and related regulatory filings.
2026-04-28 Chinese
南华生物关于调整董事会各专门委员会委员的公告
Board/Management Information Classification · 100% confidence The document is an announcement regarding changes in the composition of the company's board committees, specifically the resignation of a non-independent director and the election of new committee members. It details the updated membership of the board's specialized committees. There is no financial data, no mention of annual or quarterly reports, no voting results, and no other types of filings. This fits the definition of Board/Management Information (MANG), which covers announcements of changes in the company's board of directors or senior management.
2026-04-28 Chinese
南华生物2025年度董事会工作报告
Board/Management Information Classification · 95% confidence The document is titled '2025年度董事会工作报告' which translates to '2025 Annual Board of Directors Work Report'. It details the board's activities, meetings, decisions, and governance matters throughout the year 2025. It includes summaries of financial performance, board meeting counts and topics, independent directors' duties, committee activities, and plans for 2026. The content focuses on the board's work and governance rather than full financial statements or audit opinions. This matches the description of 'Board/Management Information (MANG)', which covers announcements of changes and reports related to the company's board and senior management activities. The document is about the board's work report, not a full annual report or audit report. Therefore, the correct classification is MANG with high confidence.
2026-04-28 Chinese
南华生物独立董事2025年年度述职报告（佘利文）
Board/Management Information Classification · 95% confidence The document is titled as an "Independent Director's Annual Report" for the year 2025 from a company. It details the independent director's duties, attendance at board and committee meetings, supervision of financial reporting, internal controls, audit processes, governance activities including board re-election, and protection of shareholder interests. The content is a detailed narrative of the independent director's activities and oversight during the fiscal year, consistent with a management or board-related report rather than a full annual report or audit report. It is not a financial statement or earnings release, nor is it a regulatory filing or announcement. The document is a formal report by a board member on their duties and activities, which fits best under Board/Management Information (MANG). The document length (4528 characters) is sufficient for a substantive report, not a brief announcement. Therefore, the classification is MANG with high confidence.
2026-04-28 Chinese
南华生物2025内控控制审计报告
Audit Report / Information Classification · 95% confidence The document is titled as an "内部控制审计报告" (Internal Control Audit Report) and includes detailed information about the internal control audit of the company's financial reporting as of December 31, 2025. It contains the auditor's opinion on the effectiveness of internal controls, references to relevant auditing standards, and detailed internal control evaluation criteria. The document is about the audit of internal controls over financial reporting, not the full annual report or financial statements. It is a standalone audit report focused on internal control effectiveness, which fits the definition of an Audit Report / Information (AR). The document length is 4050 characters, which is consistent with a detailed audit report rather than a brief announcement or certification. Therefore, the appropriate classification is AR with high confidence. FY 2025
2026-04-28 Chinese

Browse filings by year

29 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.